Bicycle Therapeutics Plc - ADR Live Stock Price Today, Share Analysis and Chart

Name: Bicycle Therapeutics Plc - ADR: Is Infosys Ltd. worth buying?
Item: Bicycle Therapeutics Plc - ADR
Rating: 1.32475
Author: Trendlyne DVM scores

about

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural ge...

7.07 0.05 (0.71%)

75.34% Fall from 52W High

370.9K

XNAS Volume

XNAS 12 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

19.0 / 100

Technically Bearish

34.0 / 100

1Yr Price target upside is 238%

11 analysts

Bicycle Therapeutics Plc ADR Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Bicycle Therapeutics Plc - ADR Live Stock Price Today, Share Analysis and Chart

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural ge...

75.34% Fall from 52W High

SWOT Analysis

Bicycle Therapeutics Plc ADR Live Price Chart